US Patent Litigations are now available. Check here
Explore detailed information on the case number ACT_459916/2023 involving Amgen Inc. and Regeneron Pharmaceuticals Inc., Sanofi-Aventis Groupe S.A., Sanofi Winthrop Industrie S.A., and others. Get insights into the proceedings, key dates, and all parties involved. Stay informed with the latest updates from IP Verse.
Case Details
Amgen Inc.
Regeneron Pharmaceuticals Inc.
Sanofi-Aventis Groupe S.A.
Sanofi Winthrop Industrie S.A.
Sanofi-Aventis Deutschland Gmbh
Matthias Zigann
Samuel Granata
Tobias Pichlmaier
Xavier DORLAND-GALLIOT
More cases on
Sanofi-Aventis Deutschland Gmbh
Sanofi Winthrop Industrie S.A.
Sanofi-Aventis Groupe
Amgen
Amgen
Sanofi-Aventis Deutschland Gmbh
Sanofi-Aventis Groupe
Sanofi Winthrop Industrie S.A.
More cases on Amgen Inc.
Amgen Europe B.V.
Amgen Inc.
Amgen B.V.
Amgen S.R.L.
Amgen Nv
Amgen Gmbh
Amgen S.A.S.
Regeneron Pharmaceuticals Inc.
Amgen Inc.
Sanofi Winthrop Industrie S.A.
Sanofi-Aventis Deutschland Gmbh
Regeneron Pharmaceuticals Inc.
Sanofi-Aventis Groupe S.A.
More cases on Regeneron Pharmaceuticals Inc.
Amgen Europe B.V.
Amgen Inc.
Amgen B.V.
Amgen S.R.L.
Amgen Nv
Amgen Gmbh
Amgen S.A.S.
Regeneron Pharmaceuticals Inc.
Amgen Inc.
Sanofi Winthrop Industrie S.A.
Sanofi-Aventis Deutschland Gmbh
Regeneron Pharmaceuticals Inc.
Sanofi-Aventis Groupe S.A.